1-3 of 3
Martin E. Gleave
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer

Matti Annala, Gillian Vandekerkhove, Daniel Khalaf, Sinja Taavitsainen, Kevin Beja, Evan W. Warner, Katherine Sunderland, Christian Kollmannsberger, Bernhard J. Eigl, Daygen Finch, Conrad D. Oja, Joanna Vergidis, Muhammad Zulfiqar, Arun A. Azad, Matti Nykter, Martin E. Gleave, Alexander W. Wyatt, Kim N. Chi
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2018) 8 (4): 444–457.
https://doi.org/10.1158/2159-8290.CD-17-0937
Published: 01 April 2018
View article titled, Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
Open the PDF for Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer

Jennifer L. Bishop, Daksh Thaper, Sepideh Vahid, Alastair Davies, Kirsi Ketola, Hidetoshi Kuruma, Randy Jama, Ka Mun Nip, Arkhjamil Angeles, Fraser Johnson, Alexander W. Wyatt, Ladan Fazli, Martin E. Gleave, Dong Lin, Mark A. Rubin, Colin C. Collins, Yuzhuo Wang, Himisha Beltran, Amina Zoubeidi
Journal: Cancer Discovery
Cancer Discov (2017) 7 (1): 54–71.
https://doi.org/10.1158/2159-8290.CD-15-1263
Published: 05 January 2017
View article titled, The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer
Open the PDF for The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets

Himisha Beltran, David S. Rickman, Kyung Park, Sung Suk Chae, Andrea Sboner, Theresa Y. MacDonald, Yuwei Wang, Karen L. Sheikh, Stéphane Terry, Scott T. Tagawa, Rajiv Dhir, Joel B. Nelson, Alexandre de la Taille, Yves Allory, Mark B. Gerstein, Sven Perner, Kenneth J. Pienta, Arul M. Chinnaiyan, Yuzhuo Wang, Colin C. Collins, Martin E. Gleave, Francesca Demichelis, David M. Nanus, Mark A. Rubin
Journal: Cancer Discovery
Cancer Discov (2011) 1 (6): 487–495.
https://doi.org/10.1158/2159-8290.CD-11-0130
Published: 16 November 2011
View article titled, Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
Open the PDF for Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets in another window
Includes: Supplementary data